Berlin Atrial Fibrillation Registry

Completed

• Conditions: Atrial Fibrillation; Acute Ischemic Stroke

• Registration Number: NCT02306824
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

Investigator-initiated prospective multicentre hospital-based registry to uncover the proportion of self-reported anticoagulation in stroke patients with atrial fibrillation and assessing the proportion of stroke, intracranial bleeding and all-cause death in the short (at 3 months), mid-term (at 12 months) as well as long term (at 24 months) after ischemic stroke or transient ischemic attack in an unselected urban population in Germany. In addition, annual follow-up is planned yearly up to 5 years after enrollment.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-11-30
• Study Start: 2014-12
• Study First Submitted QC: 2014-12-02
• Study First Posted: 2014-12-03
• Primary Completion: 2017-11
• Status Verified: 2020-11
• Study Completion: 2020-11
• Last Update Submitted: 2020-11-10
• Last Update Posted: 2020-11-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1080

Inclusion Criteria

• Acute ischemic stroke or transient ischemic attack (with clinical deficit on admission or corresponding brain MRI lesion)
• Age ≥ 18 years
• Known atrial fibrillation or ECG recording documenting atrial fibrillation during the in-hospital stay for acute ischemic stroke or transient ischemic attack
• Written or oral informed consent
• Willingness to take part in the planned follow up examinations

Exclusion Criteria

• Life expectancy < 1 year (before stroke)
• Assumed post-stroke life expectancy < 1 month according to stroke severity
• Chronic anticoagulation for reasons other than atrial fibrillation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient self-reported persistence to oral anticoagulants (novel oral anticoagulants or vitamin K antagonists) in stroke patients with AF at 12 months after ischemic stroke or TIA	12 months

Trial Locations

Locations (1)

Charité - Universitätsmedizin Berlin; 🇩🇪 Berlin, Germany